Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
2020 ◽
Vol 146
(4)
◽
pp. 863-874
◽
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 62
(10)
◽
pp. 1499-1510
◽
Keyword(s):
2003 ◽
Vol 13
◽
pp. S388-S389
◽
Keyword(s):
2019 ◽
Vol 407
◽
pp. 116419
◽
Keyword(s):
Keyword(s):